87447-47-0 (beta-1,3,5(10)-三烯-3,17β-二醇,Des5-(2-dimethylamino)ethyl Diltiazem)

CAS号:
87447-47-0
中文名称:
beta-1,3,5(10)-三烯-3,17β-二醇
英文名称:
Des5-(2-dimethylamino)ethyl Diltiazem
安全信息:
分子式:
C18H17NO4S
分子量:
343.39688372612

beta-1,3,5(10)-三烯-3,17β-二醇(87447-47-0)名称与标识符

名称

中文别名:
去[5-(2-二甲氨基)乙基]地尔硫卓;地尔硫卓杂质B;(2S-顺式)-3-(乙酰基氧基)-2,3-二氢-2-(4-甲氧基苯基)-1,5-苯并噻嗪革-4(5h)-酮;地尔硫杂质B;盐酸地尔硫卓杂质B(EP) 标准品;bata-雌二醇;beta-1,3,5(10)-三烯-3,17β-二醇;(2S,3S)-3-(乙酰氧基)-2,3-二氢-2-(4-甲氧基苯基)-1,5-苯并硫氮杂卓-4(5H)-酮;盐酸地尔硫卓杂质B;
英文别名:
1,5-Benzothiazepin-4(5H)-one,3-(acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-, (2S,3S)-;(2S)-cis-3-(Acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one;[(2S,3S)-2-(4-methoxyphenyl)-4-oxo-3,5-dihydro-2H-1,5-benzothiazepin-3-yl] acetate;DES[5-(2-DIMETHYLAMINO)ETHYL] DILTIAZEM;A9559_FLUKA;(2S,3S)-3-(Acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one (ACI);1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-cis)- (ZCI);Diltiazem Hydrochloride,Imp. B (EP): (2S,3S)-2-(4-Methoxyphenyl)- 4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin- 3-yl Acetate;(2S,3S)-2-(4-Methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-ylacetate;A825VH5J6V;SCHEMBL7343478;Diltiazem EP Impurity B;1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-, (2S,3S)-;(2S-CIS)-3-(ACETYLOXY)-2,3-DIHYDRO-2-(4-METHOXY-PHENYL)-1,5-BENZOTHIAZEPIN-4(5H)-ONE;DTXSID00455591;DILTIAZEM HYDROCHLORIDE IMPURITY B [EP IMPURITY];cis(+)-3-acetyloxy-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one;(2S,3S)-2-(4-Methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate;1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-cis)-;(2S)-cis-3-(Acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one, analytical standard;Diltiazem hydrochloride impurity B [EP];UNII-A825VH5J6V;(2S,3S)-2-(4-Methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl Acetate;Diltiazem Hydrochloride Imp. B (EP); Diltiazem Imp. B (EP); (2S,3S)-2-(4-Methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl Acetate; Diltiazem Hydrochloride Impurity B; Diltiazem Impurity B;87447-47-0;WKLRIRQZTCFCSE-SJORKVTESA-N;(2S-cis)-3-(Acetyloxy)2,3-dihydro-2-(4-methoxy-phenyl)-1,5-benzothiazepin-4(5H)-one;

标识符

MDL:
MFCD00153902
InChIKey:
WKLRIRQZTCFCSE-SJORKVTESA-N
Inchi:
1S/C18H17NO4S/c1-11(20)23-16-17(12-7-9-13(22-2)10-8-12)24-15-6-4-3-5-14(15)19-18(16)21/h3-10,16-17H,1-2H3,(H,19,21)/t16-,17+/m1/s1
SMILES:
O([C@H]1C(=O)NC2C=CC=CC=2S[C@H]1C1C=CC(OC)=CC=1)C(=O)C

beta-1,3,5(10)-三烯-3,17β-二醇(87447-47-0)物化性质

实验特性

  • LogP : 3.55040
  • PSA : 89.93000
  • 折射率 : 1.637
  • 沸点 : 535.908°C at 760 mmHg
  • 熔点 : 147-150?C
  • 闪点 : 277.907°C
  • 溶解度 : 几乎不溶 (0.076 g/L) (25 ºC),
  • 密度 : 1.33±0.1 g/cm3 (20 ºC 760 Torr),

计算特性

  • 精确分子量 : 343.08800
  • 氢键供体数量 : 1
  • 氢键受体数量 : 5
  • 可旋转化学键数量 : 4
  • 同位素质量 : 343.08782920g/mol
  • 重原子数量 : 24
  • 复杂度 : 464
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 2
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2.8
  • 拓扑分子极性表面积 : 89.9Ų

beta-1,3,5(10)-三烯-3,17β-二醇(87447-47-0)安全信息

beta-1,3,5(10)-三烯-3,17β-二醇(87447-47-0)合成路线

合成路线:1 步
反应条件:
参考文献:
Some applications of isopropenyl acetate to O-, N- and C-acetylation
Gizur, Tibor; et al, Synthetic Communications, 1990, 20(15), 2365-71
合成路线:1 步
反应条件:
参考文献:
Biocatalytic dynamic reductive kinetic resolution of aryl α-chloro β-keto esters: divergent, stereocontrolled synthesis of diltiazem, clentiazem, and siratiazem
Yue, Xiaoping; et al, Chemical Communications (Cambridge, 2022, 58(64), 9010-9013
合成路线:2 步
反应条件:
参考文献:
Biocatalytic dynamic reductive kinetic resolution of aryl α-chloro β-keto esters: divergent, stereocontrolled synthesis of diltiazem, clentiazem, and siratiazem
Yue, Xiaoping; et al, Chemical Communications (Cambridge, 2022, 58(64), 9010-9013
合成路线:3 步
反应条件:
参考文献:
Biocatalytic dynamic reductive kinetic resolution of aryl α-chloro β-keto esters: divergent, stereocontrolled synthesis of diltiazem, clentiazem, and siratiazem
Yue, Xiaoping; et al, Chemical Communications (Cambridge, 2022, 58(64), 9010-9013
合成路线:4 步
反应条件:
参考文献:
Biocatalytic dynamic reductive kinetic resolution of aryl α-chloro β-keto esters: divergent, stereocontrolled synthesis of diltiazem, clentiazem, and siratiazem
Yue, Xiaoping; et al, Chemical Communications (Cambridge, 2022, 58(64), 9010-9013
合成路线:5 步
反应条件:
参考文献:
Biocatalytic dynamic reductive kinetic resolution of aryl α-chloro β-keto esters: divergent, stereocontrolled synthesis of diltiazem, clentiazem, and siratiazem
Yue, Xiaoping; et al, Chemical Communications (Cambridge, 2022, 58(64), 9010-9013
合成路线:6 步
反应条件:
参考文献:
Biocatalytic dynamic reductive kinetic resolution of aryl α-chloro β-keto esters: divergent, stereocontrolled synthesis of diltiazem, clentiazem, and siratiazem
Yue, Xiaoping; et al, Chemical Communications (Cambridge, 2022, 58(64), 9010-9013
合成路线:1 步
反应条件:
参考文献:
Access to drug metabolites via C-H functionalization: copper-catalyzed aerobic oxidation of N,N-dimethylalkylamines in complex pharmaceuticals
Genovino, Julien; et al, Tetrahedron Letters, 2015, 56(23), 3066-3069